ASIT Biotech SA (EUR)
ASIT
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range0.29 | 0.30
52-Wk Range0.26 | 3.04
Last Close0.29
Mkt Cap (m)6.39
Dividend yield-
ISINBE0974289218
Volume56,393
Exchange VenueBRU

Company Profile

ASIT Biotech SA is a clinical stage biopharmaceutical company. The company is engaged in the development and future commercialization of a range of breakthrough immunotherapy products for the treatment of allergies, based on its ASIT+ technology platform.

Key Information
Price/Earning-
Price/Book4.06
Price/Sales-
P/CF-
Rev Growth (3 year avg)-
EPS Growth (3 year avg)-
Operating Margin % -
Net Margin %-
Return on Equity-373.58
Debt/Equity0.33

Legal Documents

Prospectus
en 07/03/2018
Annual Report
en 31/12/2018

Financials

Income Statement
EUR201320142015201620172018
Revenue (m)
Operating Income (m)-2-4-8-12-12-13
Net Income (m)-2-4-8-12-12-14
Basic EPS-0.27-0.76-0.91-1.10-0.94-0.86
Avg. Diluted Shares Outstanding (m)969111317
Balance Sheet
EUR201320142015201620172018
Current Assets (m)1951429
Non Current Assets (m)1222
Total Assets (m)19516912
Current Liabilities (m)16235
Total Liabilities (m)------
Total Equity (m)7-11316
Cash Flows
EUR201320142015201620172018
Operating Cash Flows (m)-2-3-8-14-13-13
Capital Expenditure (m)
Figures are quoted in EUR unless stated otherwise
0.01 (1.71%)
0.30
Last Price